US 11492406
Methods and compositions for treating and preventing disease associated with alpha-v beta-8 integrin
granted A61PA61P11/00A61P37/00
Quick answer
US patent 11492406 (Methods and compositions for treating and preventing disease associated with alpha-v beta-8 integrin) held by The Regents of the University of California expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Nov 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P11/00, A61P37/00